698 related articles for article (PubMed ID: 18845195)
1. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
2. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate.
Gao Y; Sun Y; Ren F; Gao S
Drug Dev Ind Pharm; 2010 Oct; 36(10):1131-8. PubMed ID: 20334543
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
5. Barriers to glaucoma drug delivery.
Ghate D; Edelhauser HF
J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
7. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
8. Contact lenses for drug delivery.
Ciolino JB; Dohlman CH; Kohane DS
Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
[TBL] [Abstract][Full Text] [Related]
9. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
10. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
11. Vesicular systems in ocular drug delivery: an overview.
Kaur IP; Garg A; Singla AK; Aggarwal D
Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
[TBL] [Abstract][Full Text] [Related]
12. The potential of chitosan in ocular drug delivery.
Alonso MJ; Sánchez A
J Pharm Pharmacol; 2003 Nov; 55(11):1451-63. PubMed ID: 14713355
[TBL] [Abstract][Full Text] [Related]
13. [The deleterious effect of certain surface active agents on the ocular surface].
Ravet O
Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
[TBL] [Abstract][Full Text] [Related]
14. [Bioavailability of drugs applied to the eye externally].
Sieradzki E
Klin Oczna; 1991 Jan; 93(1):34-6. PubMed ID: 2046287
[TBL] [Abstract][Full Text] [Related]
15. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
16. Industrial perspective in ocular drug delivery.
Ali Y; Lehmussaari K
Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of ocular drug penetration.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
[TBL] [Abstract][Full Text] [Related]
18. [Ways to improve ocular bioavailability for topical applications].
Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
Attar M; Shen J; Ling KH; Tang-Liu D
Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
